Related references
Note: Only part of the references are listed.Feed-forward regulatory loop driven by IRF4 and NF-κB in adult T-cell leukemia/lymphoma
Regina Wan Ju Wong et al.
BLOOD (2020)
HTLV-1 induces T cell malignancy and inflammation by viral antisense factor-mediated modulation of the cytokine signaling
Yusuke Higuchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Arsenic trioxide (As2O3) as a maintenance therapy for adult T cell leukemia/lymphoma
Ambroise Marcais et al.
RETROVIROLOGY (2020)
Targeting immune cells for cancer therapy
Sin Yee Gun et al.
REDOX BIOLOGY (2019)
Sporadic on/off switching of HTLV-1 Tax expression is crucial to maintain the whole population of virus-induced leukemic cells
Mohamed Mahgoub et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection
Huseini Kagdi et al.
PLOS PATHOGENS (2018)
Epidemiology, clinical features, and outcome of HTLV-1-related ATLL in an area of prevalence in the United States
Luis Malpica et al.
BLOOD ADVANCES (2018)
Regulation of normal and leukemic stem cells through cytokine signaling and the microenvironment
Virginia Camacho et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)
IL-10-mediated signals act as a switch for lymphoproliferation in Human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways
Leila Sawada et al.
PLOS PATHOGENS (2017)
Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study
Youko Suehiro et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
ATL response to arsenic/interferon therapy is triggered by SUMO/PML/RNF4-dependent Tax degradation
Zeina Dassouki et al.
BLOOD (2015)
Activation of a promyelocytic leukemia-tumor protein 53 axis underlies acute promyelocytic leukemia cure
Julien Ablain et al.
NATURE MEDICINE (2014)
The combination of arsenic, interferon-alpha, and zidovudine restores an immunocompetent-like cytokine expression profile in patients with adult T-cell leukemia lymphoma
Ghada Kchour et al.
RETROVIROLOGY (2013)
Depletion and Reconstitution of Macrophages in Mice
Shelley B. Weisser et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2012)
Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy
M. Matsuoka et al.
ONCOGENE (2011)
Meta-Analysis on the Use of Zidovudine and Interferon-Alfa in Adult T-Cell Leukemia/Lymphoma Showing Improved Survival in the Leukemic Subtypes
Ali Bazarbachi et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia
Hiba El Hajj et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL)
Ghada Kchour et al.
BLOOD (2009)
IL-10: The master regulator of immunity to infection
Kevin N. Couper et al.
JOURNAL OF IMMUNOLOGY (2008)
Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation
Rihab Nasr et al.
NATURE MEDICINE (2008)
Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I
H Hasegawa et al.
NATURE MEDICINE (2006)
NOD/SCID/γcnull mouse:: an excellent recipient mouse model for engraftment of human cells
M Ito et al.
BLOOD (2002)
Arsenic trioxide induces apoptosis in human T-cell leukemia virus type 1-and type 2-infected cells by a caspase-3-dependent mechanism involving Bcl-2 cleavage
R Mahieux et al.
BLOOD (2001)
Share Paper
